Who am I?
I’m Dr. Amie Wilson, International Trial co-ordinator for the AIMS Trial (Antibiotics In Miscarriage Surgery). I am a midwife with a true passion for improving maternal health in low resource setting.
What is the research?
AIMS is an international study working to improve miscarriage care in low income countries. The study will involve 3400 women from Malawi, Tanzania, Uganda and Pakistan. Miscarriage is common and affects around 20 million women every year. The study will tell us if giving a single dose of antibiotics before surgery for miscarriage will reduce infection. Continue reading
Dentistry PhD student Pip White has won 1st prize at the OMIG (Oral Microbiology and Immunology Group) Postgraduate Prize meeting ACTA, which took place in Amsterdam on 12th February 2015. Pip’s talk was entitled ‘The interactions between periodontal bacteria and neutrophil extracellular traps in periodontitis’. Congratulations Pip!
The Wellcome Trust has published a press release about its revised funding approach which is available here, and a Q&A to accompany the news here.
The Strategic Framework 2010-15, Shaping Our Future, launched a period of intensive transformation, ambition, innovation, and success at the University of Birmingham, which culminated in the University’s being named The Times/Sunday Times University of the Year 2013-2014. Five years ago many of you took part in the development of the Strategic Framework and shared ideas, comments and suggestions, which helped shape our success. Continue reading
Students in Dentistry win prestigious national prizes for their research:
Praveen Sharma in the Periodontal Research Group has won the Sir Wilfred Fish Prize at the Presidential British Society for Periodontology meeting in September 2014. The Sir Wilfred Fish Research Prize, instituted in 1970, is awarded annually by the British Society of Periodontology, with the object of encouraging researchers in the early stages of their career. The Prize takes the form of a cash award of £1000 together with a certificate. This is the second year running that the PRG have had a winner of this prize (last year’s was won by Martin Ling) and have had six winners in total.
Binish Khatoon, whose PhD is in educational research into mobile learning, has been awarded 1st prize in the British Dental Editors Forum Young Communicator of the Year Award for her paper ‘Can we learn, teach and practise dentistry anywhere, anytime?’ British Dental Journal 2013; 215: 345-347. This national award is given to a young person who has created a significant dental communication such as a refereed article, journalism, social media, video, podcast, or any other form of communication.
Well done to both students for these great achievements.
A guest post from Jon Frampton, Director of Research and
Knowledge Transfer and Professor of Stem Cell Biology
As we reach our momentous 100th post on the MDS Research & Knowledge Transfer blog we launched just months ago, there have been many things to celebrate and opportunities to engage with. However, as with everything in life there are lots of things we could have done or could be doing better, faster and more productively, as well as activities as a research support office that you think would be useful that we may not be doing at all.
With all that in mind, we would like to take the opportunity to ask our wonderful research community – “If you could change just one thing about the research support you receive, what would it be?”.
Do you suffer from visual stress? The symptoms of visual stress include the perception of visual distortions (illusory movement, shimmer, flicker, coloured halos), eye strain, as well as nausea, visual discomfort, and dizziness.
Studies are currently underway in the School of Psychology, University of Birmingham that are investigating the role of visual stress and associated visual distortions and hallucinations.
If you suffer from visual distortions, visual stress, and / or visual hallucinations and would like to volunteer to take part in these studies please contact Dr Jason Braithwaite.
For more information, please see the Visual stress flyer.
Business Secretary Vince Cable recently announced a new scheme to grant UK researchers access to a range of valuable deprioritised pharmaceutical compounds.
This is being led by the Medical Research Council in partnership with seven global pharmaceutical companies: AstraZeneca, GlaxoSmithKline, Janssen Research & Development LLC, Lilly, Pfizer, Takeda and UCB.
This will allow researchers to conduct new studies to improve our understanding of disease, which could in turn lead to more effective treatments.
The compounds have all undergone some industry development but were not effective enough against the target disease. However, they could be used to fight other diseases with similar pathways.
For more information please see the original article.